Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks
| ISSN: |
1435-4373
|
|---|---|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Abstract In vitro susceptibility tests were performed with 350 selected strains ofStreptococcus pneumoniae to evaluate disk diffusion tests with 30 μg and 1 μg cefotaxime disks. Zones were compared to MICs of cefotaxime with and without its desacetyl metabolite. Cefotaxime was two to eight times more active than desacetyl cefotaxime, but the two compounds were additive when combined in vitro. For 30 μg disks, zone size breakpoints were ≤27 mm, 28–30 mm and ≥31 mm for resistant, intermediate and susceptible, respectively. For 1 μg disks, those zone size criteria were reduced to ≤13 mm, 14–16 mm and ≥17 mm. The 30 μg disk that is currently available for testing other species can be used for testing pneumococci; however, the 1 μg disk has some important advantages.
|
| Type of Medium: |
Electronic Resource
|
| URL: |
| _version_ | 1798296204476416000 |
|---|---|
| autor | Barry, A. L. Brown, S. D. Novick, W. J. |
| autorsonst | Barry, A. L. Brown, S. D. Novick, W. J. |
| book_url | http://dx.doi.org/10.1007/BF01690885 |
| datenlieferant | nat_lic_papers |
| hauptsatz | hsatz_simple |
| identnr | NLM206284764 |
| issn | 1435-4373 |
| journal_name | European journal of clinical microbiology & infectious diseases |
| materialart | 1 |
| notes | Abstract In vitro susceptibility tests were performed with 350 selected strains ofStreptococcus pneumoniae to evaluate disk diffusion tests with 30 μg and 1 μg cefotaxime disks. Zones were compared to MICs of cefotaxime with and without its desacetyl metabolite. Cefotaxime was two to eight times more active than desacetyl cefotaxime, but the two compounds were additive when combined in vitro. For 30 μg disks, zone size breakpoints were ≤27 mm, 28–30 mm and ≥31 mm for resistant, intermediate and susceptible, respectively. For 1 μg disks, those zone size criteria were reduced to ≤13 mm, 14–16 mm and ≥17 mm. The 30 μg disk that is currently available for testing other species can be used for testing pneumococci; however, the 1 μg disk has some important advantages. |
| package_name | Springer |
| publikationsjahr_anzeige | 1995 |
| publikationsjahr_facette | 1995 |
| publikationsjahr_intervall | 8004:1995-1999 |
| publikationsjahr_sort | 1995 |
| publisher | Springer |
| reference | 14 (1995), S. 724-726 |
| search_space | articles |
| shingle_author_1 | Barry, A. L. Brown, S. D. Novick, W. J. |
| shingle_author_2 | Barry, A. L. Brown, S. D. Novick, W. J. |
| shingle_author_3 | Barry, A. L. Brown, S. D. Novick, W. J. |
| shingle_author_4 | Barry, A. L. Brown, S. D. Novick, W. J. |
| shingle_catch_all_1 | Barry, A. L. Brown, S. D. Novick, W. J. Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks Abstract In vitro susceptibility tests were performed with 350 selected strains ofStreptococcus pneumoniae to evaluate disk diffusion tests with 30 μg and 1 μg cefotaxime disks. Zones were compared to MICs of cefotaxime with and without its desacetyl metabolite. Cefotaxime was two to eight times more active than desacetyl cefotaxime, but the two compounds were additive when combined in vitro. For 30 μg disks, zone size breakpoints were ≤27 mm, 28–30 mm and ≥31 mm for resistant, intermediate and susceptible, respectively. For 1 μg disks, those zone size criteria were reduced to ≤13 mm, 14–16 mm and ≥17 mm. The 30 μg disk that is currently available for testing other species can be used for testing pneumococci; however, the 1 μg disk has some important advantages. 1435-4373 14354373 Springer |
| shingle_catch_all_2 | Barry, A. L. Brown, S. D. Novick, W. J. Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks Abstract In vitro susceptibility tests were performed with 350 selected strains ofStreptococcus pneumoniae to evaluate disk diffusion tests with 30 μg and 1 μg cefotaxime disks. Zones were compared to MICs of cefotaxime with and without its desacetyl metabolite. Cefotaxime was two to eight times more active than desacetyl cefotaxime, but the two compounds were additive when combined in vitro. For 30 μg disks, zone size breakpoints were ≤27 mm, 28–30 mm and ≥31 mm for resistant, intermediate and susceptible, respectively. For 1 μg disks, those zone size criteria were reduced to ≤13 mm, 14–16 mm and ≥17 mm. The 30 μg disk that is currently available for testing other species can be used for testing pneumococci; however, the 1 μg disk has some important advantages. 1435-4373 14354373 Springer |
| shingle_catch_all_3 | Barry, A. L. Brown, S. D. Novick, W. J. Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks Abstract In vitro susceptibility tests were performed with 350 selected strains ofStreptococcus pneumoniae to evaluate disk diffusion tests with 30 μg and 1 μg cefotaxime disks. Zones were compared to MICs of cefotaxime with and without its desacetyl metabolite. Cefotaxime was two to eight times more active than desacetyl cefotaxime, but the two compounds were additive when combined in vitro. For 30 μg disks, zone size breakpoints were ≤27 mm, 28–30 mm and ≥31 mm for resistant, intermediate and susceptible, respectively. For 1 μg disks, those zone size criteria were reduced to ≤13 mm, 14–16 mm and ≥17 mm. The 30 μg disk that is currently available for testing other species can be used for testing pneumococci; however, the 1 μg disk has some important advantages. 1435-4373 14354373 Springer |
| shingle_catch_all_4 | Barry, A. L. Brown, S. D. Novick, W. J. Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks Abstract In vitro susceptibility tests were performed with 350 selected strains ofStreptococcus pneumoniae to evaluate disk diffusion tests with 30 μg and 1 μg cefotaxime disks. Zones were compared to MICs of cefotaxime with and without its desacetyl metabolite. Cefotaxime was two to eight times more active than desacetyl cefotaxime, but the two compounds were additive when combined in vitro. For 30 μg disks, zone size breakpoints were ≤27 mm, 28–30 mm and ≥31 mm for resistant, intermediate and susceptible, respectively. For 1 μg disks, those zone size criteria were reduced to ≤13 mm, 14–16 mm and ≥17 mm. The 30 μg disk that is currently available for testing other species can be used for testing pneumococci; however, the 1 μg disk has some important advantages. 1435-4373 14354373 Springer |
| shingle_title_1 | Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks |
| shingle_title_2 | Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks |
| shingle_title_3 | Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks |
| shingle_title_4 | Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks |
| sigel_instance_filter | dkfz geomar wilbert ipn albert fhp |
| source_archive | Springer Online Journal Archives 1860-2000 |
| timestamp | 2024-05-06T09:48:23.277Z |
| titel | Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks |
| titel_suche | Criteria for testing the susceptibility ofStreptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 μg or 30 μg cefotaxime disks |
| topic | WW-YZ |
| uid | nat_lic_papers_NLM206284764 |